Evoke Pharma, Inc. Gains 37.16%
Wed, Dec 07, 2022 at 07:00 PM
Evoke Pharma, Inc. (EVOK:NASDAQ) shot up at $2.03, representing a gain of 37.2%. On Wed, Dec 07, 2022, EVOK:NASDAQ touched a New 2-Week High of $2.03. The stock appeared on our News Catalysts scanner on Wed, Dec 07, 2022 at 10:09 AM in the 'PRIVATE PLACEMENT' category. From Wed, Nov 23, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days
About Evoke Pharma, Inc. (EVOK:NASDAQ)
Evoke Pharma Inc is a specialty pharmaceutical company which focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. It is engaged in developing an investigational metoclopramide nasal spray called Gimoti.
Top 10 Gainers:
- Ignyta, Inc. (RXDX:NASDAQ), 165.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 133.44%
- FLJ Group Limited (FLJ:NASDAQ), 57.3%
- Vor Biopharma Inc. (VOR:NASDAQ), 41.86%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 37.16%
- Summit Therapeutics plc (SMMT:NASDAQ), 33.33%
- NexGel Inc (NXGL:NASDAQ), 28.33%
- Eargo Inc. (EAR:NASDAQ), 27.48%
- Bit Brother Limited (BTB:NASDAQ), 23.65%
- MongoDB, Inc. (MDB:NASDAQ), 23.23%